Actively Recruiting

Age: 18Years +
All Genders
NCT07270861

Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

Led by Fudan University · Updated on 2026-03-24

3000

Participants Needed

1

Research Sites

528 weeks

Total Duration

On this page

Sponsors

F

Fudan University

Lead Sponsor

T

The First Affiliated Hospital of Zhengzhou University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study aims to characterize the epidemiology, clinicopathologic features, and survival outcomes of Chinese patients with PTCL; to develop and validate prognostic models to this population; to compare the real-world effectiveness and safety of alternative therapeutic strategies; to elucidate molecular mechanisms underlying treatment resistance and relapse; to identify actionable targets and predictive biomarkers.

CONDITIONS

Official Title

Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older with a confirmed histopathologic diagnosis of PTCL according to WHO 2016 classification
  • Patients diagnosed and treated at participating centers between 2010 and 2024 (Cohort A)
  • Patients newly diagnosed from October 2025 onward (Cohort B)
  • Availability of basic diagnostic and treatment records
Not Eligible

You will not qualify if you...

  • Unclear diagnosis or missing pathology report
  • Patients diagnosed outside who did not receive primary treatment and follow-up at participating centers
  • Diagnosis of NK/T-cell lymphoma or primary cutaneous T-cell lymphoma

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China, 201200

Actively Recruiting

Loading map...

Research Team

R

Rong Tao, MD

CONTACT

C

Chuanxu Liu, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here